Country - United States
Summary - Mrna Manufacturing Facility In Kenya
Deadline - login to view
MT reference number - 10468780
Product classification -
Address - United States
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 10468780
Document Type - Tender Notices
Description - Scope : Moderna has signed a memorandum of understanding (MoU) with the Government of the Republic of Kenya to build a messenger ribonucleic acid (mRNA) manufacturing facility in the country.The MoU was signed by the company with assistance from the US Government.Moderna is establishing this facility in Africa to manufacture up to 500 million vaccines doses per year. The company plans to invest up to $500m in this new plant, which is intended to carry out drug substance production for Kenya.The facility might be extended to incorporate fill/finish as well as packaging expertise at the site. The mRNA pipeline of the company in its preventive vaccines modality comprises 28 vaccine programmes i
Mt Ref Id - 10468780
Deadline - Dec 31, 2023
View more tenders for
United States Tenders